These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 25282488

  • 1. [Current management of thalassemia intermedia].
    Thuret I.
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [Abstract] [Full Text] [Related]

  • 2. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
    Asadov C, Alimirzoeva Z, Mammadova T, Aliyeva G, Gafarova S, Mammadov J.
    Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
    [Abstract] [Full Text] [Related]

  • 3. Thalassemia intermedia: revisited.
    Taher A, Isma'eel H, Cappellini MD.
    Blood Cells Mol Dis; 2006 Jul; 37(1):12-20. PubMed ID: 16737833
    [Abstract] [Full Text] [Related]

  • 4. New therapeutic targets in transfusion-dependent and -independent thalassemia.
    Cappellini MD, Motta I.
    Hematology Am Soc Hematol Educ Program; 2017 Dec 08; 2017(1):278-283. PubMed ID: 29222267
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.
    Cario H, Wegener M, Debatin KM, Kohne E.
    Ann Hematol; 2002 Aug 08; 81(8):478-82. PubMed ID: 12224008
    [Abstract] [Full Text] [Related]

  • 13. Morbidities in non-transfusion-dependent thalassemia.
    Saliba AN, Taher AT.
    Ann N Y Acad Sci; 2016 Mar 08; 1368(1):82-94. PubMed ID: 27186941
    [Abstract] [Full Text] [Related]

  • 14. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A, El-Ghamrawy M, EL-Ela MA, Said F, Adolf S, Abdel-Razek AR, Magdy RI, Abdel-Salam A.
    Ann Hematol; 2014 Dec 08; 93(12):2045-50. PubMed ID: 25062719
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An update on thalassemia intermedia.
    Maakaron JE, Cappellini MD, Taher AT.
    J Med Liban; 2013 Dec 08; 61(3):175-82. PubMed ID: 24422369
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Guidelines for diagnosis and management of Beta-thalassemia intermedia.
    Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A.
    Pediatr Hematol Oncol; 2014 Oct 08; 31(7):583-96. PubMed ID: 25247665
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.